← Back to Clinical Trials
Recruiting NCT07557732

NCT07557732 Engaging Mental Effort: Process- and Person-Based Reward Experiences, Effort Reinforcement Intervention, and Cascading Effects on Challenging Tasks

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07557732
Status Recruiting
Phase
Sponsor University of California, Davis
Condition Performance vs. Effort Rewards
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2026-04-08
Primary Completion 2028-09-01

Eligibility & Interventions

Sex All sexes
Min Age 9 Years
Max Age 13 Years
Study Type INTERVENTIONAL
Interventions
Performance RewardsEffort Rewards

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2026-04-08 with a primary completion date of 2028-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Brief Summary: The goal of this clinical trial is to investigate the influences of children's prior experiences with rewards following successes at school and interventions aimed at influencing children's preferences for challenging cognitive tasks. The main questions this study aims to answer are as follows: 1. Does the frequency of process-based rewards (e.g., rewards for working hard) vs. outcomes-based rewards (i.e., rewards for a good grade) predict children's preferences for challenging cognitive tasks? 2. Does providing rewards for taking on effortful cognitive tasks increase children's preferences for challenging cognitive tasks more than providing rewards for performing well on cognitive tasks? 3. Does receiving rewards for taking on effortful cognitive tasks increase children's challenge-seeking in novel tasks and questionnaires relevant for academic achievement that have not been previously linked with rewards? Participants will complete the following tasks: 1. A matrix completion problem solving task, with options to seek tips for solving problems and options to quit early. 2. A response inhibition task, with options to complete a harder or easier version of the task. 3. A cognitive flexibility task, with options to complete a harder or easier version of the task. 4. A puzzle completion task, with an option to quit early. 5. Answer a set of questions about academic effort 6. Parents will complete a set of questions about how they responded to children's recent successes and failures at school.

Eligibility Criteria

Inclusion Criteria: \- Children aged 9.00-13.00 years Exclusion Criteria: * Known or diagnosed developmental disorder (autism, ADHD, other learning disorders or developmental delays)

Contact & Investigator

Central Contact

Jesse C Niebaum, PhD

✉ jcniebaum@ucdavis.edu

📞 530-752-1011

Principal Investigator

Jesse Niebaum, PhD

STUDY DIRECTOR

University of California, Davis

Frequently Asked Questions

Who can join the NCT07557732 clinical trial?

This trial is open to participants of all sexes, aged 9 Years or older, up to 13 Years, studying Performance vs. Effort Rewards. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07557732 currently recruiting?

Yes, NCT07557732 is actively recruiting participants. Contact the research team at jcniebaum@ucdavis.edu for enrollment information.

Where is the NCT07557732 trial being conducted?

This trial is being conducted at Davis, United States.

Who is sponsoring the NCT07557732 clinical trial?

NCT07557732 is sponsored by University of California, Davis. The principal investigator is Jesse Niebaum, PhD at University of California, Davis. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology